114 related articles for article (PubMed ID: 16180546)
1. Immunogenicity and protective effect of a DNA construct encoding certain neutralizing epitopes of herpes simplex virus type-1 glycoprotein B.
Bamdad T; Roostaee MH; Sadeghizadeh M; Mahboudi F; Kazemnejad A; Soleimanjahi H
Folia Biol (Praha); 2005; 51(4):109-13. PubMed ID: 16180546
[TBL] [Abstract][Full Text] [Related]
2. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization.
Kuklin N; Daheshia M; Karem K; Manickan E; Rouse BT
J Virol; 1997 Apr; 71(4):3138-45. PubMed ID: 9060677
[TBL] [Abstract][Full Text] [Related]
3. Protective immunity against lethal HSV-1 challenge in mice by nucleic acid-based immunisation with herpes simplex virus type-1 genes specifying glycoproteins gB and gD.
Baghian A; Chouljenko VN; D'Auvergne O; Newman MJ; Baghian S; Kousoulas KG
J Med Microbiol; 2002 Apr; 51(4):350-357. PubMed ID: 11926742
[TBL] [Abstract][Full Text] [Related]
4. Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge.
Ghiasi H; Cai S; Slanina S; Nesburn AB; Wechsler SL
Antiviral Res; 1995 Oct; 28(2):147-57. PubMed ID: 8585768
[TBL] [Abstract][Full Text] [Related]
5. Intravascular naked DNA vaccine encoding glycoprotein B induces protective humoral and cellular immunity against herpes simplex virus type 1 infection in mice.
Cui FD; Asada H; Kishida T; Itokawa Y; Nakaya T; Ueda Y; Yamagishi H; Gojo S; Kita M; Imanishi J; Mazda O
Gene Ther; 2003 Dec; 10(25):2059-66. PubMed ID: 14595378
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of apoptotic and anti-apoptotic genes on efficacy of DNA vaccine encoding glycoprotein B of Herpes Simplex Virus type 1.
Parsania M; Bamdad T; Hassan ZM; Kheirandish M; Pouriayevali MH; Sari RD; Jamali A
Immunol Lett; 2010 Feb; 128(2):137-42. PubMed ID: 20026118
[TBL] [Abstract][Full Text] [Related]
7. Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone.
Meseda CA; Elkins KL; Merchlinsky MJ; Weir JP
J Infect Dis; 2002 Oct; 186(8):1065-73. PubMed ID: 12355355
[TBL] [Abstract][Full Text] [Related]
8. Antibody response and protective capacity of plasmid vaccines expressing three different herpes simplex virus glycoproteins.
Nass PH; Elkins KL; Weir JP
J Infect Dis; 1998 Sep; 178(3):611-7. PubMed ID: 9728527
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.
BenMohamed L; Bertrand G; McNamara CD; Gras-Masse H; Hammer J; Wechsler SL; Nesburn AB
J Virol; 2003 Sep; 77(17):9463-73. PubMed ID: 12915561
[TBL] [Abstract][Full Text] [Related]
10. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens.
Karem KL; Bowen J; Kuklin N; Rouse BT
J Gen Virol; 1997 Feb; 78 ( Pt 2)():427-34. PubMed ID: 9018066
[TBL] [Abstract][Full Text] [Related]
11. Coexpression of interleukin-2 enhances the immunization effect of a DNA vaccine expressing herpes simplex 1 glycoprotein D.
Li WR; Niu B; Wang JW; Feng ZJ; Wang DX
Acta Virol; 2006; 50(4):251-6. PubMed ID: 17177610
[TBL] [Abstract][Full Text] [Related]
12. Expression of the herpes simplex virus type 1 glycoprotein E in human cells and in Escherichia coli: protection studies against lethal viral infection in mice.
Miriagou V; Argnani R; Kakkanas A; Georgopoulou U; Manservigi R; Mavromara P
J Gen Virol; 1995 Dec; 76 ( Pt 12)():3137-43. PubMed ID: 8847521
[TBL] [Abstract][Full Text] [Related]
13. Enhanced protection against HSV lethal challenges in mice by immunization with a combined HSV-1 glycoprotein B:H:L gene DNAs.
Cha SC; Kim YS; Cho JK; Cho J; Kim SY; Kang H; Cho MH; Lee HH
Virus Res; 2002 Jun; 86(1-2):21-31. PubMed ID: 12076826
[TBL] [Abstract][Full Text] [Related]
14. The effect of DNA priming-protein boosting on enhancing humoral immunity and protecting mice against lethal HSV infections.
Soleimanjahi H; Roostaee MH; Rasaee MJ; Mahboudi F; Kazemnejad A; Bamdad T; Zandi K
FEMS Immunol Med Microbiol; 2006 Feb; 46(1):100-6. PubMed ID: 16420602
[TBL] [Abstract][Full Text] [Related]
15. Induction of humoral and cellular immunity against latent HSV-1 infections by DNA immunization in BALB/c mice.
Ghaemi A; Soleimanjahi H; Bamdad T; Soudi S; Arefeian E; Hashemi SM; Ebtekar M
Comp Immunol Microbiol Infect Dis; 2007 Jul; 30(4):197-210. PubMed ID: 17335902
[TBL] [Abstract][Full Text] [Related]
16. Co-immunization with plasmids coding the full length and a soluble form of glycoprotein D of HSV-2 induces protective cellular and humoral immune response in mice.
Fló J
Vaccine; 2003 Mar; 21(11-12):1239-45. PubMed ID: 12559804
[TBL] [Abstract][Full Text] [Related]
17. Protective immunity against herpes simplex virus generated by DNA vaccination compared to natural infection.
Nass PH; Elkins KL; Weir JP
Vaccine; 2001 Jan; 19(11-12):1538-46. PubMed ID: 11163680
[TBL] [Abstract][Full Text] [Related]
18. A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus.
Du R; Wang L; Xu H; Wang Z; Zhang T; Wang M; Ning Y; Deng F; Hu Z; Wang H; Li Y
Antiviral Res; 2017 Nov; 147():131-141. PubMed ID: 29061442
[TBL] [Abstract][Full Text] [Related]
19. Identification of B- and T-cell epitopes from glycoprotein B of herpes simplex virus 2 and evaluation of their immunogenicity and protection efficacy.
Liu K; Jiang D; Zhang L; Yao Z; Chen Z; Yu S; Wang X
Vaccine; 2012 Apr; 30(19):3034-41. PubMed ID: 22008818
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
